Zhengye Biotechnology Holding (ZYBT) Equity Ratio (2023 - 2024)

Zhengye Biotechnology Holding (ZYBT) has disclosed Equity Ratio for 2 consecutive years, with 0.71 as the latest value for Q4 2024.

  • Quarterly Equity Ratio rose 30.95% to 0.71 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.71 through Dec 2024, up 30.95% year-over-year, with the annual reading at 0.58 for FY2024, 5.47% up from the prior year.
  • Equity Ratio for Q4 2024 was 0.71 at Zhengye Biotechnology Holding, up from 0.55 in the prior quarter.
  • The five-year high for Equity Ratio was 0.71 in Q4 2024, with the low at 0.55 in Q4 2023.